Wilkinson.
Pharmac is often criticised for not funding enough new medicines and for being too slow to determine which ones it will fund. However, being slow and focused is not proof of being too slow or too focused.
Does access to medicines differ from access to healthcare? Experiences of barriers to medicines access by people facing social disadvantage
Does access to medicines differ from access to healthcare? Experiences of barriers to medicines access by people facing social disadvantage
Levesque et al.’s widely-cited five dimensional model of access to healthcare has been used in a variety of contexts, including access to medicines.
